Who Owns TERN?

Terns Pharmaceuticals, Inc. — Institutional Ownership & 13F Holdings

$52.97

+0.02 (+0.04%)

Market Cap

$4.8B

Shares Outstanding

90,077,698

Institutional Holders

138

Total Inst. Value

$214.0M

% of Float Held

97.3%

QoQ Holder Change

+41

Institutional data as of Q1 2025

New Positions

27

Closed Positions

42

Increased

46

Decreased

40

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Soleus Capital Management, L.P.$22.5M8,167,100
2ORBIMED ADVISORS LLC$20.9M7,562,971
3MORGAN STANLEY$19.6M7,110,105
4Vivo Capital, LLC$19.0M6,895,746
5BlackRock, Inc.$15.8M5,706,632
6Deep Track Capital, LP$15.4M5,576,558
7VANGUARD GROUP INC$11.5M4,152,156
8Schonfeld Strategic Advisors LLC$10.6M3,844,867
9Candriam S.C.A.$5.9M2,153,969
10ACORN CAPITAL ADVISORS, LLC$5.4M1,971,264

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold TERN?

As of Q1 2025, 138 institutional investors report holding TERN (Terns Pharmaceuticals, Inc.) in their 13F filings.

What percentage of Terns Pharmaceuticals, Inc. is owned by institutions?

Institutional investors hold approximately 97.3% of Terns Pharmaceuticals, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most TERN?

The largest institutional holder of TERN is Soleus Capital Management, L.P. with $22.5M in shares.

Are institutions buying or selling TERN?

This quarter, 27 institutions opened new positions in TERN and 42 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.